|
Market Closed -
NYSE
16:00:02 2026-08-21 EDT
|
5-day change | 1st Jan Change | ||
| 93.02 USD | -0.67% |
|
-4.26% | +17.21% |
| 08-19 | Argus Adjusts Price Target on CVS Health to $114 From $104, Keeps Buy Rating | MT |
| 08-17 | CVS Health Names JPMorgan's Heitsenrether to Board | MT |
| Market Cap | 119B 102B 95.35B 87.29B 164B 11,383B 166B 1,127B 439B 5,718B 447B 437B 18,913B | P/E 2026 * |
13.7x | P/E 2027 * | 13.1x |
|---|---|---|---|---|---|
| Enterprise Value | 171B 146B 137B 125B 235B 16,350B 238B 1,618B 631B 8,213B 642B 628B 27,167B | EV / Sales 2026 * |
0.41x | EV / Sales 2027 * | 0.39x |
| Free-Float |
71.17% | Yield 2026 * |
2.86% | Yield 2027 * | 2.94% |
Last Transcript: CVS Health Corporation
| 1 day | -0.67% | ||
| 1 week | -4.26% | ||
| Current month | -10.93% | ||
| 1 month | -15.90% | ||
| 3 months | -0.32% | ||
| 6 months | +21.29% | ||
| Current year | +17.21% |
| 1 week | 92.35 |  | 96.5 |
| 1 month | 92.35 | | 110 |
| Current year | 69.51 | | 110.68 |
| 1 year | 69.51 | | 110.68 |
| 3 years | 43.56 | | 110.68 |
| 5 years | 43.56 | | 111.25 |
| 10 years | 43.56 | | 111.25 |
| Manager | Title | Age | Since |
|---|---|---|---|
J. Joyner
CEO | Chief Executive Officer | 62 | 2024-10-16 |
Ali Keshavarz
PSD | President | - | - |
Brian Newman
DFI | Director of Finance/CFO | 57 | 2025-05-11 |
| Director | Title | Age | Since |
|---|---|---|---|
C. Brown
BRD | Director/Board Member | 74 | 2007-02-28 |
Anne Finucane
BRD | Director/Board Member | 73 | 2011-01-19 |
| Director/Board Member | 71 | 2015-03-04 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 5/14/26 | Free | Director | 1,737 | 0.0001% | ||
| 2/28/26 | Tax | Executive/Senior Manager | 7,886 | 0.0006% | ||
| 2/28/26 | Tax | Chief Executive Officer | 1,944 | 0.0002% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.67% | -4.26% | +30.23% | +38.67% | 119B | |
| +5.64% | +6.06% | +6.17% | +56.17% | 92.92B | |
| +1.28% | +4.26% | +33.02% | +83.90% | 26.97B | |
| -0.25% | +4.12% | -3.92% | -8.54% | 22.17B | |
| +3.00% | +4.80% | +58.28% | +291.97% | 22.61B | |
| +1.48% | +1.75% | -8.03% | +14.24% | 14.47B | |
| -1.83% | -2.19% | -7.94% | -8.92% | 12.42B | |
| -0.81% | -3.47% | +26.34% | +70.60% | 11.08B | |
| +2.54% | +4.26% | -3.64% | +38.16% | 10.45B | |
| -0.17% | -1.29% | -20.24% | +80.89% | 10.14B | |
| Average | +1.02% | +1.40% | +11.03% | +65.72% | 34.22B | |
| Weighted average by Cap. | +1.62% | +1.06% | +17.90% | +60.17% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 418B 358B 335B 306B 575B 39,968B 583B 3,956B 1,543B 20,078B 1,569B 1,534B 66,408B | 430B 368B 344B 315B 592B 41,107B 599B 4,068B 1,587B 20,650B 1,613B 1,578B 68,301B |
| Net income | 8.8B 7.54B 7.05B 6.46B 12.11B 842B 12.27B 83.32B 32.49B 423B 33.04B 32.32B 1,399B | 9.1B 7.8B 7.3B 6.68B 12.54B 871B 12.7B 86.21B 33.62B 438B 34.18B 33.44B 1,447B |
| Net Debt | 51.92B 44.47B 41.61B 38.09B 71.48B 4,967B 72.43B 492B 192B 2,495B 195B 191B 8,253B | 49.15B 42.1B 39.39B 36.06B 67.67B 4,702B 68.56B 465B 181B 2,362B 185B 181B 7,813B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-21 | US$93.02 | -0.67% | 5,591,986 |
| 26-08-20 | US$93.65 | 0.00% | 6,439,680 |
| 26-08-19 | US$93.65 | -1.33% | 6,351,620 |
| 26-08-18 | US$94.91 | +0.96% | 6,855,122 |
| 26-08-17 | US$94.01 | -3.24% | 7,298,832 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CVS Stock
Select your edition
All financial news and data tailored to specific country editions
